Portfolio Holdings Detail for ISIN IE00BG11HV38
Stock Name / Fund iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker EEWD(USD) LSE
ETF Ticker EEWG(GBP) LSE
ETF Ticker EEWDx(GBP) CXE
ETF Ticker EMND.DE(EUR) CXE
ETF Ticker EEWD.L(GBP) LSE
ETF Ticker EEWG.L(GBP) LSE

Holdings detail for LLY

Stock Name	Eli Lilly and Company
Ticker	LLY(EUR) F
TYPE	Common Stock
Country	Germany
ISIN	US5324571083
LEI	FRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG: Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs: With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About: Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price: Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial: (RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY: The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today: Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock: Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years: Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever: Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years: Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?: Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!: My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks: In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?: Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies: Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats: Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble: Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years: Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade: Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way: Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly: In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis: Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.: Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now: Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks: Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?: Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy: In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP LLY holdings

Date	Number of LLY Shares Held	Base Market Value of LLY Shares	Local Market Value of LLY Shares	Change in LLY Base Value	Current Price per LLY Share Held	Previous Price per LLY Share Held
2026-01-14 (Wednesday)	67,660	USD 72,618,801	USD 72,618,801	USD -521,659	USD 1073.29	USD 1081
2026-01-12 (Monday)	67,660	USD 73,140,460	USD 73,140,460	USD 1,179,990	USD 1081	USD 1063.56
2026-01-09 (Friday)	67,660	USD 71,960,470	USD 71,960,470	USD -1,463,485	USD 1063.56	USD 1085.19
2026-01-08 (Thursday)	67,660	USD 73,423,955	USD 73,423,955	USD -1,549,414	USD 1085.19	USD 1108.09
2026-01-07 (Wednesday)	67,660	USD 74,973,369	USD 74,973,369	USD 1,876,211	USD 1108.09	USD 1080.36
2026-01-02 (Friday)	67,660	USD 73,097,158	USD 73,097,158	USD 384,309	USD 1080.36	USD 1074.68
2025-12-31 (Wednesday)	67,660	USD 72,712,849	USD 72,712,849	USD -274,023	USD 1074.68	USD 1078.73
2025-12-29 (Monday)	67,660	USD 72,986,872	USD 72,986,872	USD 66,307	USD 1078.73	USD 1077.75

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE00BG11HV38

Show aggregate share trades of LLY

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-19 SELL -214 1,075.380 1,059.395 1,060.994 EUR -227,053 832.95 Loss of -48,802 on sale
2025-12-17 BUY 214 1,064.300 1,036.420 1,039.208 EUR 222,391 831.16
2025-12-16 SELL -214 1,068.230 1,036.230 1,039.430 EUR -222,438 830.23 Loss of -44,769 on sale
2025-12-15 SELL -226 1,065.000 1,032.550 1,035.795 EUR -234,090 829.26 Loss of -46,676 on sale
2025-12-10 SELL -339 1,003.000 977.120 979.708 EUR -332,121 827.82 Loss of -51,491 on sale
2025-12-08 BUY 113 1,014.200 989.000 991.520 EUR 112,042 827.10
2025-12-02 SELL -535 1,068.180 1,040.360 1,043.142 EUR -558,081 824.48 Loss of -116,983 on sale
2025-11-20 BUY 904 1,057.000 1,038.250 1,040.125 EUR 940,273 815.50
2025-11-18 BUY 297 1,040.724 1,017.255 1,019.602 EUR 302,822 813.50
2025-11-12 SELL -565 1,022.420 990.100 993.332 EUR -561,233 809.71 Loss of -103,746 on sale
2025-11-10 BUY 339 981.990 938.830 943.146 EUR 319,726 808.17
2025-11-05 BUY 791 955.410 908.230 912.948 EUR 722,142 806.48
2025-10-27 SELL -565 826.410 826.420 826.419 EUR -466,927 804.92 Loss of -12,149 on sale
2025-10-20 SELL -339 808.960 809.410 809.365 EUR -274,375 804.71 Loss of -1,580 on sale
2025-10-15 BUY 2,034 826.570 830.190 829.828 EUR 1,687,870 804.53
2025-10-13 BUY 452 819.400 835.320 833.728 EUR 376,845 804.42
2025-10-02 BUY 107 819.850 834.460 832.999 EUR 89,131 804.34
2025-10-01 BUY 1,500 825.420 833.300 832.512 EUR 1,248,768 804.23
2025-09-26 BUY 321 724.540 729.000 728.554 EUR 233,866 805.26
2025-09-24 SELL -41 741.850 746.940 746.431 EUR -30,604 806.07 Profit of 2,445 on sale
2025-08-04 BUY 1,344 769.000 774.480 773.932 EUR 1,040,165 810.66
2025-07-16 BUY 112 789.800 796.040 795.416 EUR 89,087 812.47
2025-07-10 SELL -530 790.650 799.490 798.606 EUR -423,261 813.04 Profit of 7,648 on sale
2025-07-02 BUY 224 779.280 779.840 779.784 EUR 174,672 814.27
2025-06-02 SELL -448 747.120 747.370 747.345 EUR -334,811 818.65 Profit of 31,945 on sale
2025-05-30 BUY 2,933 737.670 745.900 745.077 EUR 2,185,311 819.23
2025-05-29 SELL -324 722.570 727.330 726.854 EUR -235,501 819.92 Profit of 30,152 on sale
2025-05-28 SELL -108 719.390 729.990 728.930 EUR -78,724 820.64 Profit of 9,905 on sale
2025-05-22 SELL -1,620 715.200 722.190 721.491 EUR -1,168,815 823.71 Profit of 165,597 on sale
2025-05-16 BUY 206 757.390 758.870 758.722 EUR 156,297 826.08
2025-05-14 BUY 324 715.560 759.500 755.106 EUR 244,654 827.66
2025-05-13 BUY 1,836 746.060 759.500 758.156 EUR 1,391,974 828.29
2025-05-12 SELL -108 755.570 765.330 764.354 EUR -82,550 828.87 Profit of 6,967 on sale
2025-04-25 BUY 480 884.540 885.580 885.476 EUR 425,028 829.68
2025-04-23 SELL -214 829.420 846.010 844.351 EUR -180,691 829.42 Loss of -3,195 on sale
2025-04-22 SELL -1,070 827.540 832.000 831.554 EUR -889,763 829.44 Loss of -2,265 on sale
2025-04-11 BUY 204 732.410 735.840 735.497 EUR 150,041 832.54
2025-04-09 BUY 204 753.710 754.830 754.718 EUR 153,962 834.38
2025-04-08 SELL -515 726.240 763.500 759.774 EUR -391,284 835.42 Profit of 38,960 on sale
2025-04-07 SELL -729 723.730 748.000 745.573 EUR -543,523 836.52 Profit of 66,300 on sale
2025-04-04 BUY 107 738.210 768.270 765.264 EUR 81,883 837.49
2025-03-27 BUY 428 821.670 826.770 826.260 EUR 353,639 838.47
2025-03-11 BUY 2,675 824.060 832.350 831.521 EUR 2,224,319 839.57
2025-03-07 BUY 214 869.580 908.000 904.158 EUR 193,490 839.32
2025-03-06 BUY 204 912.760 931.380 929.518 EUR 189,622 838.42
2025-03-03 SELL -408 929.720 935.630 935.039 EUR -381,496 835.14 Loss of -40,757 on sale
2025-02-28 SELL -2,540 920.630 921.220 921.161 EUR -2,339,749 834.03 Loss of -221,304 on sale
2025-02-26 BUY 4,346 915.010 922.430 921.688 EUR 4,005,656 832.01
2025-02-18 SELL -3,024 857.200 862.730 862.177 EUR -2,607,223 828.21 Loss of -102,731 on sale
2025-02-13 BUY 428 871.860 883.500 882.336 EUR 377,640 827.06
2024-12-09 BUY 224 803.580 823.700 821.688 EUR 184,058 827.45
2024-12-04 SELL -560 829.840 846.460 844.798 EUR -473,087 827.45 Loss of -9,715 on sale
2024-12-03 SELL -2,464 813.330 817.130 816.750 EUR -2,012,472 827.76 Profit of 27,135 on sale
2024-11-25 SELL -1,752 755.000 755.000 755.000 EUR -1,322,760 837.54 Profit of 144,618 on sale
2024-11-25 SELL -1,752 755.000 755.000 755.000 EUR -1,322,760 837.54 Profit of 144,618 on sale
2024-11-19 SELL -110 729.730 730.000 729.973 EUR -80,297 848.73 Profit of 13,063 on sale
2024-11-18 SELL -115 727.200 734.000 733.320 EUR -84,332 852.53 Profit of 13,709 on sale
2024-11-12 BUY 345 818.860 833.990 832.477 EUR 287,205 853.61
2024-11-01 SELL -920 818.930 833.000 831.593 EUR -765,066 886.48 Profit of 50,493 on sale
2024-11-01 SELL -920 818.930 833.000 831.593 EUR -765,066 886.48 Profit of 50,493 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-19	SELL	-214	1,075.380	1,059.395	1,060.994	EUR -227,053	832.95 Loss of -48,802 on sale
2025-12-17	BUY	214	1,064.300	1,036.420	1,039.208	EUR 222,391	831.16
2025-12-16	SELL	-214	1,068.230	1,036.230	1,039.430	EUR -222,438	830.23 Loss of -44,769 on sale
2025-12-15	SELL	-226	1,065.000	1,032.550	1,035.795	EUR -234,090	829.26 Loss of -46,676 on sale
2025-12-10	SELL	-339	1,003.000	977.120	979.708	EUR -332,121	827.82 Loss of -51,491 on sale
2025-12-08	BUY	113	1,014.200	989.000	991.520	EUR 112,042	827.10
2025-12-02	SELL	-535	1,068.180	1,040.360	1,043.142	EUR -558,081	824.48 Loss of -116,983 on sale
2025-11-20	BUY	904	1,057.000	1,038.250	1,040.125	EUR 940,273	815.50
2025-11-18	BUY	297	1,040.724	1,017.255	1,019.602	EUR 302,822	813.50
2025-11-12	SELL	-565	1,022.420	990.100	993.332	EUR -561,233	809.71 Loss of -103,746 on sale
2025-11-10	BUY	339	981.990	938.830	943.146	EUR 319,726	808.17
2025-11-05	BUY	791	955.410	908.230	912.948	EUR 722,142	806.48
2025-10-27	SELL	-565	826.410	826.420	826.419	EUR -466,927	804.92 Loss of -12,149 on sale
2025-10-20	SELL	-339	808.960	809.410	809.365	EUR -274,375	804.71 Loss of -1,580 on sale
2025-10-15	BUY	2,034	826.570	830.190	829.828	EUR 1,687,870	804.53
2025-10-13	BUY	452	819.400	835.320	833.728	EUR 376,845	804.42
2025-10-02	BUY	107	819.850	834.460	832.999	EUR 89,131	804.34
2025-10-01	BUY	1,500	825.420	833.300	832.512	EUR 1,248,768	804.23
2025-09-26	BUY	321	724.540	729.000	728.554	EUR 233,866	805.26
2025-09-24	SELL	-41	741.850	746.940	746.431	EUR -30,604	806.07 Profit of 2,445 on sale
2025-08-04	BUY	1,344	769.000	774.480	773.932	EUR 1,040,165	810.66
2025-07-16	BUY	112	789.800	796.040	795.416	EUR 89,087	812.47
2025-07-10	SELL	-530	790.650	799.490	798.606	EUR -423,261	813.04 Profit of 7,648 on sale
2025-07-02	BUY	224	779.280	779.840	779.784	EUR 174,672	814.27
2025-06-02	SELL	-448	747.120	747.370	747.345	EUR -334,811	818.65 Profit of 31,945 on sale
2025-05-30	BUY	2,933	737.670	745.900	745.077	EUR 2,185,311	819.23
2025-05-29	SELL	-324	722.570	727.330	726.854	EUR -235,501	819.92 Profit of 30,152 on sale
2025-05-28	SELL	-108	719.390	729.990	728.930	EUR -78,724	820.64 Profit of 9,905 on sale
2025-05-22	SELL	-1,620	715.200	722.190	721.491	EUR -1,168,815	823.71 Profit of 165,597 on sale
2025-05-16	BUY	206	757.390	758.870	758.722	EUR 156,297	826.08
2025-05-14	BUY	324	715.560	759.500	755.106	EUR 244,654	827.66
2025-05-13	BUY	1,836	746.060	759.500	758.156	EUR 1,391,974	828.29
2025-05-12	SELL	-108	755.570	765.330	764.354	EUR -82,550	828.87 Profit of 6,967 on sale
2025-04-25	BUY	480	884.540	885.580	885.476	EUR 425,028	829.68
2025-04-23	SELL	-214	829.420	846.010	844.351	EUR -180,691	829.42 Loss of -3,195 on sale
2025-04-22	SELL	-1,070	827.540	832.000	831.554	EUR -889,763	829.44 Loss of -2,265 on sale
2025-04-11	BUY	204	732.410	735.840	735.497	EUR 150,041	832.54
2025-04-09	BUY	204	753.710	754.830	754.718	EUR 153,962	834.38
2025-04-08	SELL	-515	726.240	763.500	759.774	EUR -391,284	835.42 Profit of 38,960 on sale
2025-04-07	SELL	-729	723.730	748.000	745.573	EUR -543,523	836.52 Profit of 66,300 on sale
2025-04-04	BUY	107	738.210	768.270	765.264	EUR 81,883	837.49
2025-03-27	BUY	428	821.670	826.770	826.260	EUR 353,639	838.47
2025-03-11	BUY	2,675	824.060	832.350	831.521	EUR 2,224,319	839.57
2025-03-07	BUY	214	869.580	908.000	904.158	EUR 193,490	839.32
2025-03-06	BUY	204	912.760	931.380	929.518	EUR 189,622	838.42
2025-03-03	SELL	-408	929.720	935.630	935.039	EUR -381,496	835.14 Loss of -40,757 on sale
2025-02-28	SELL	-2,540	920.630	921.220	921.161	EUR -2,339,749	834.03 Loss of -221,304 on sale
2025-02-26	BUY	4,346	915.010	922.430	921.688	EUR 4,005,656	832.01
2025-02-18	SELL	-3,024	857.200	862.730	862.177	EUR -2,607,223	828.21 Loss of -102,731 on sale
2025-02-13	BUY	428	871.860	883.500	882.336	EUR 377,640	827.06
2024-12-09	BUY	224	803.580	823.700	821.688	EUR 184,058	827.45
2024-12-04	SELL	-560	829.840	846.460	844.798	EUR -473,087	827.45 Loss of -9,715 on sale
2024-12-03	SELL	-2,464	813.330	817.130	816.750	EUR -2,012,472	827.76 Profit of 27,135 on sale
2024-11-25	SELL	-1,752	755.000	755.000	755.000	EUR -1,322,760	837.54 Profit of 144,618 on sale
2024-11-25	SELL	-1,752	755.000	755.000	755.000	EUR -1,322,760	837.54 Profit of 144,618 on sale
2024-11-19	SELL	-110	729.730	730.000	729.973	EUR -80,297	848.73 Profit of 13,063 on sale
2024-11-18	SELL	-115	727.200	734.000	733.320	EUR -84,332	852.53 Profit of 13,709 on sale
2024-11-12	BUY	345	818.860	833.990	832.477	EUR 287,205	853.61
2024-11-01	SELL	-920	818.930	833.000	831.593	EUR -765,066	886.48 Profit of 50,493 on sale
2024-11-01	SELL	-920	818.930	833.000	831.593	EUR -765,066	886.48 Profit of 50,493 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	432,038	935	1,319,853	32.7%
2025-09-18	547,818	126	1,290,147	42.5%
2025-09-17	437,337	427	1,166,204	37.5%
2025-09-16	532,698	1,829	1,463,374	36.4%
2025-09-15	424,979	701	1,071,487	39.7%
2025-09-12	267,121	172	826,802	32.3%
2025-09-11	249,803	1,484	850,461	29.4%
2025-09-10	415,442	1,025	989,008	42.0%
2025-09-09	559,805	667	1,270,800	44.1%
2025-09-08	856,018	4,682	1,937,447	44.2%
2025-09-05	679,276	1,050	1,405,239	48.3%
2025-09-04	337,491	53	982,751	34.3%
2025-09-03	214,691	496	766,157	28.0%
2025-09-02	430,477	2,977	1,131,908	38.0%
2025-08-29	357,538	602	889,509	40.2%
2025-08-28	433,687	1,099	1,113,568	38.9%
2025-08-27	860,715	6,009	1,681,353	51.2%
2025-08-26	1,548,460	12,105	2,955,348	52.4%
2025-08-25	566,454	3,586	1,323,249	42.8%
2025-08-22	749,615	1,957	1,460,713	51.3%
2025-08-21	651,639	223	1,570,067	41.5%
2025-08-20	679,554	2,698	1,870,241	36.3%
2025-08-19	787,909	935	2,788,740	28.3%
2025-08-18	756,143	1,095	1,727,603	43.8%
2025-08-15	1,814,721	836	3,422,260	53.0%
2025-08-14	1,852,940	5,382	3,602,829	51.4%
2025-08-13	1,254,225	3,473	2,774,100	45.2%
2025-08-12	990,110	3,190	2,845,896	34.8%
2025-08-11	1,290,063	1,615	5,196,302	24.8%
2025-08-08	2,448,706	300,870	6,239,830	39.2%
2025-08-07	4,197,951	489,618	10,364,294	40.5%
2025-08-06	440,144	1,120	1,811,262	24.3%
2025-08-05	331,460	921	993,178	33.4%
2025-08-04	474,905	1,408	1,273,995	37.3%
2025-08-01	530,569	7,139	1,882,098	28.2%
2025-07-31	882,506	3,670	2,110,030	41.8%
2025-07-30	745,614	392	1,827,435	40.8%
2025-07-29	1,081,849	571	2,607,245	41.5%
2025-07-28	304,841	7,460	1,004,032	30.4%
2025-07-25	365,417	265	1,055,273	34.6%
2025-07-24	321,799	762	1,167,147	27.6%
2025-07-23	485,719	3,471	1,044,919	46.5%
2025-07-22	241,098	3,036	874,717	27.6%
2025-07-21	418,014	854	1,180,445	35.4%
2025-07-18	623,498	651	1,225,333	50.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	EEWD(USD) LSE
ETF Ticker	EEWG(GBP) LSE
ETF Ticker	EEWDx(GBP) CXE
ETF Ticker	EMND.DE(EUR) CXE
ETF Ticker	EEWD.L(GBP) LSE
ETF Ticker	EEWG.L(GBP) LSE